| |
Latest 10 SEC filings (by transaction date) for MNKD within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 29/24 | Mar 27/24 | Sabella Lauren M | Direct Ownership | Common Stock, $.01 Par Value | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -17,084 | $4.63 |
Feb 5/24 | Feb 4/24 | Tross Stuart A | Direct Ownership | Common Stock, $0.01 Par Value | A - Grant, award or other under Rule 16b-3(d) | 15,290 | $3.27 |
Feb 5/24 | Feb 4/24 | Blank Burkhard | Direct Ownership | Common Stock, $0.01 Par Value | A - Grant, award or other under Rule 16b-3(d) | 152,905 | $3.27 |
Feb 5/24 | Feb 4/24 | Kay Sabrina | Direct Ownership | Common Stock, $0.01 Par Value | A - Grant, award or other under Rule 16b-3(d) | 107,033 | $3.27 |
Feb 5/24 | Feb 4/24 | Hooper Anthony C | Direct Ownership | Common Stock, $0.01 Par Value | A - Grant, award or other under Rule 16b-3(d) | 40,000 | $3.27 |
Feb 5/24 | Feb 4/24 | Sabella Lauren M | Direct Ownership | Common Stock, $0.01 Par Value | A - Grant, award or other under Rule 16b-3(d) | 15,290 | $3.27 |
Feb 5/24 | Feb 4/24 | Consiglio Ronald J | Direct Ownership | Common Stock, $0.01 Par Value | A - Grant, award or other under Rule 16b-3(d) | 25,000 | $3.27 |
Feb 5/24 | Feb 4/24 | Castagna Michael | Direct Ownership | Common Stock, $0.01 Par Value | A - Grant, award or other under Rule 16b-3(d) | 30,581 | $3.27 |
Feb 5/24 | Dec 31/23 | Tross Stuart A | Direct Ownership | Common Stock, $0.01 Par Value | A - Grant, award or other under Rule 16b-3(d) | 1,006 | $3.09 |
Feb 5/24 | Dec 31/23 | Blank Burkhard | Direct Ownership | Common Stock, $0.01 Par Value | A - Grant, award or other under Rule 16b-3(d) | 5,000 | $3.09 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for MNKD within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 29/24 | Mar 27/24 | Sabella Lauren M | Direct Ownership | Common Stock, $.01 Par Value | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -17,084 | $4.63 |
Feb 5/24 | Feb 4/24 | Tross Stuart A | Direct Ownership | Common Stock, $0.01 Par Value | A - Grant, award or other under Rule 16b-3(d) | 15,290 | $3.27 |
Feb 5/24 | Dec 31/23 | Tross Stuart A | Direct Ownership | Common Stock, $0.01 Par Value | A - Grant, award or other under Rule 16b-3(d) | 1,006 | $3.09 |
Feb 5/24 | Jun 30/23 | Tross Stuart A | Direct Ownership | Common Stock, $0.01 Par Value | A - Grant, award or other under Rule 16b-3(d) | 4,012 | $3.46 |
Feb 5/24 | Feb 4/24 | Blank Burkhard | Direct Ownership | Common Stock, $0.01 Par Value | A - Grant, award or other under Rule 16b-3(d) | 152,905 | $3.27 |
Feb 5/24 | Dec 31/23 | Blank Burkhard | Direct Ownership | Common Stock, $0.01 Par Value | A - Grant, award or other under Rule 16b-3(d) | 5,000 | $3.09 |
Feb 5/24 | Feb 4/24 | Kay Sabrina | Direct Ownership | Common Stock, $0.01 Par Value | A - Grant, award or other under Rule 16b-3(d) | 107,033 | $3.27 |
Feb 5/24 | Feb 4/24 | Hooper Anthony C | Direct Ownership | Common Stock, $0.01 Par Value | A - Grant, award or other under Rule 16b-3(d) | 40,000 | $3.27 |
Feb 5/24 | Feb 4/24 | Sabella Lauren M | Direct Ownership | Common Stock, $0.01 Par Value | A - Grant, award or other under Rule 16b-3(d) | 15,290 | $3.27 |
Feb 5/24 | Dec 31/23 | Sabella Lauren M | Direct Ownership | Common Stock, $0.01 Par Value | A - Grant, award or other under Rule 16b-3(d) | 711 | $3.09 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |